|Bid||9.05 x 400|
|Ask||11.95 x 2800|
|Day's Range||11.00 - 11.65|
|52 Week Range||3.95 - 13.60|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Redwood City, California-based company said it had net income of 2 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
Codexis (NASDAQ: CDXS ) unveils its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement. Earnings and Revenue Sell-side analysts expect ...
Codexis Inc’s (NASDAQ:CDXS): Codexis, Inc. discovers, develops, and sells protein catalysts. With the latest financial year loss of -US$8.56M and a trailing-twelve month of -US$29.23M, the US$534.23M market-cap amplifies itsRead More...
Categories: Yahoo FinanceGet free summary analysis Codexis, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Codexis, Inc. – Balchem Corporation, Pfizer Inc. and Royal Dutch Shell Plc Sponsored ADR Class A (BCPC-US, PFE-US and RDS.A-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Codexis, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)
On a per-share basis, the Redwood City, California-based company said it had a loss of 21 cents. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...